Biodesix In Brief This Week: Yourgene, Centogene, Epigenomics, AnPac Bio-Medical, Biodesix, SomaLogic News items for the week of Dec. 19, 2022. In Brief This Week: Biocept, Thermo Fisher, Biodesix, More News items for the week of Nov. 21, 2022. Biodesix to Sell $35.1M in Common Stock, Inks $50M Loan Agreement Earlier this month, the Boulder, Colorado-based diagnostics firm reported ending the third quarter with $15.2 million in cash and cash equivalents. In Brief This Week: Sophia Genetics, Sense Biodetection, Yourgene, Biodesix, DermTech, Chembio, More News items for the week of Oct. 31, 2022. Biodesix Nabs US Federal Supply Schedule Contract for Lung Cancer Tests The company's full lung cancer diagnostic menu will be covered for eligible veterans, active-duty military, and their families. Oct 14, 2022 In Brief This Week: Thermo Fisher Scientific, Enzo Biochem, Codex DNA, More Aug 5, 2022 Earnings Roundup: Waters, Personalis, Opko Health, Biodesix, Exagen Jun 3, 2022 Biodesix, Memorial Sloan Kettering Team on Minimal Residual Disease Test May 11, 2022 Biodesix, Sera Prognostics, Aspira, Epigenomics Post Q1 Financial Results Apr 11, 2022 Biodesix Raises $11.7M in Private Placement, Amends Loan Agreement Mar 14, 2022 Biodesix Q4 Revenues Decline 73 Percent on Drop in COVID-19 Testing Mar 8, 2022 Biodesix Inks $50M Stock Sale Agreement Jan 21, 2022 New Products Posted to GenomeWeb: Biodesix, Curio Genomics, Akoya Biosciences, More Jan 5, 2022 Biodesix Raises Approximately $16.3M in Sale of Common Shares, Amends $30M Term Loan Dec 1, 2021 Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests Nov 15, 2021 Biodesix Q3 Revenues Down 29 Percent on Lower COVID-19 Test Sales but Tops Estimates Oct 27, 2021 Biodesix Aims to Makes its AI-Driven Diagnostic Algorithms More Transparent for Physicians Premium Aug 10, 2021 Biodesix Q2 Revenues Shoot up but Fall Short of Wall Street Expectations Jun 4, 2021 Biodesix, Datavant Join in Lung Cancer Data Partnership May 11, 2021 Biodesix Q1 Revenues Soar on COVID-19 Testing Apr 19, 2021 Biodesix's Proteomic Method for Predicting Immunotherapy Response Advancing Toward Market Premium Mar 24, 2021 Biodesix Secures $30M Term Loan Mar 16, 2021 Biodesix Q4 Revenues More Than Triple on COVID-19 Testing Jan 8, 2021 Biodesix Preliminary Q4 Revenues Up Over 200 Percent Dec 11, 2020 Biodesix Q3 Revenues Rise Sharply Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.